Author

Haifang Cao

Observed name: Cao, Haifang

Institution: Tianjin University

Observed institution: Tianjin University

ORCID: 0009-0000-1099-182X

Observed ORCID: 0009-0000-1099-182X

OpenAlex ID: A5101377156

Autoencoder-Based Collaborative Attention GAN for Multi-Modal Image Synthesis

2023 · Bing Cao, Haifang Cao, et al. · IEEE Transactions on Multimedia · 28

Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial

2025 · Hongmin Wang, Xiaoying Li, et al. · BMJ Open · 3

Hyperbolic-Euclidean Deep Mutual Learning

2025 · Haifang Cao, Yu Wang, et al. · 3

Machine learning model for HBsAg seroclearance after 48-week pegylated interferon therapy in inactive HBsAg carriers: a retrospective study

2025 · Jianxia Dong, Shan Ren, et al. · Virology Journal · 2

The Safety of Interferon‐Based Therapies in Chronic Hepatitis B Patients With Compensatory Cirrhosis

2026 · Qiran Zhang, Taoran Geng, et al. · Portal hypertension & cirrhosis · 1

FRI-420 Serum HBsAg rather than HBV DNA reflects liver HBV transcript levels of hepatitis B patients treated by nucleoside analogues

2024 · Wenhua Zhang, Haitao Tang, et al. · Journal of Hepatology · 1

Topology-Adaptive Hyperbolic Graph Attention Networks Guided by the Hyperbolic Sombor Index

2026 · Cao, Haifang, Tao, Boan, et al. · arXiv (Cornell University)

SAGE: Source-Anchored Guidance via Frequency Equalization for Hierarchical RGB-T Alignment and Fusion

2026 · Li, Timing, Sun, Yiming, et al. · arXiv (Cornell University)

Nucleos(t)ide analogue therapy combined with pegylated interferon α-2b guided by the GOLDEN prediction model for functional cure of chronic hepatitis B: study protocol (GIFT project)

2026 · Shiqi Chai, Jingjing Jiang, et al. · BMJ Open

FRI-618 Characteristics of circulating immune cells in pediatric patients with chronic hepatitis B undergoing antiviral therapy

2026 · Haifang Cao, Hong Zhang, et al. · Journal of Hepatology

FRI-617 Peginterferon alpha-2b and nucleos(t)ide analogs combination therapy for chronic hepatitis B patients with high HBsAg level at the end of treatment (52 weeks) from ongoing CREATED excellent study

2026 · Wenhua Zhang, Haitao Tang, et al. · Journal of Hepatology

FRI-591 Peginterferon alfa-2b–based therapy achieves higher HBsAg Loss in high-risk chronic hepatitis B patients: a prospective multicenter cohort study

2026 · Yaping Li, Haifang Cao, et al. · Journal of Hepatology

Geometric Mixture-of-Experts with Curvature-Guided Adaptive Routing for Graph Representation Learning

2026 · Cao, Haifang, Wang, Yu, et al. · arXiv (Cornell University)

Hyperbolic Cycle Alignment for Infrared–Visible Image Fusion

2026 · Timing Li, Bing Cao, et al. · IEEE Transactions on Image Processing

OS-065 The multi-center study of functional cure for inactive hepatitis B surface antigen carriers in China: interim analysis of E-cure study

2025 · Zhishuo Mo, Haifang Cao, et al. · Journal of Hepatology

THU-240 30% of inactive HBsAg carriers achieved clinical cure at 48 weeks with Pegylated Interferon alpha-2b therapy: a multicenter real- world study (STARHB Project in China)- 2.5 years data update

2025 · Shan Ren, Jing Zhao, et al. · Journal of Hepatology

Works count: 18

Citation count: 38

H-index: 3

I10-index: 1